| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b4a80ac02f1ecd0e698ec665e9b36b6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2015-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3441f502086766605aeec8d9d2f227de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61e32ac16d05fcfa98b52332d3deda70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13595c861928d7c3d0fc513e0aabb26a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4fa0ddfdbddb9dd8295272d421d2bc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b20fb144e9ab1e6843dd37814cd77de7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_112558250fd5311379568744e339f2ac |
| publicationDate |
2016-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016018045-A1 |
| titleOfInvention |
Pharmaceutical composition containing leuprolide and having both immediate and sustained release properties |
| abstract |
The present invention relates to a pharmaceutical composition containing leuprolide acetate and having both immediate and sustained release properties and, more specifically, to a pharmaceutical composition in which, on the basis of the total weight of active ingredients, leuprolide as an immediate release preparation is contained in 0.001 wt% to 25 wt%; and leuprolide contained in microspheres of a sustained release preparation is contained in 75 wt% to 99.999 wt%. The pharmaceutical composition of the present invention is characterized by satisfying both a drug immediate release property so as to realize the prompt exposure to a sufficient amount of drug at the early stage for expression of medicinal effects and a drug sustained release property for four weeks or longer, and the pharmaceutical composition is effective in the prevention and treatment of sex hormone-dependent positive or malignant diseases. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109806385-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109806385-A |
| priorityDate |
2014-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |